Kuros Biosciences AG (KURN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kuros Biosciences AG (KURN) has a cash flow conversion efficiency ratio of -0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-2.24 Million ≈ $-2.83 Million USD) by net assets (CHF72.00 Million ≈ $91.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KURN market cap for the company's overall valuation and market capitalisation.
Kuros Biosciences AG - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Kuros Biosciences AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kuros Biosciences AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kuros Biosciences AG ranked by their cash flow conversion efficiency. Explore KURN cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Riley Exploration Permian Inc
NYSE MKT:REPX
|
0.085x |
|
Tianjin Economic-technological Development Area Co Ltd
SHE:000652
|
0.044x |
|
Shanghai Orient-Chip Technology Co. Ltd. A
SHG:688061
|
N/A |
|
Recticel
BR:RECT
|
0.083x |
|
Amtran Technology Co Ltd
TW:2489
|
-0.032x |
|
Decai Decoration Co Ltd
SHG:605287
|
0.009x |
|
Ceigall India
NSE:CEIGALL
|
-0.081x |
|
Nuh Cimento Sanayi AS
IS:NUHCM
|
0.028x |
Annual Cash Flow Conversion Efficiency for Kuros Biosciences AG (2004–2025)
The table below shows the annual cash flow conversion efficiency of Kuros Biosciences AG from 2004 to 2025. View KURN stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF66.93 Million ≈ $84.62 Million |
CHF-377.87K ≈ $-477.73K |
-0.006x | -110.56% |
| 2024-12-31 | CHF58.75 Million ≈ $74.27 Million |
CHF3.14 Million ≈ $3.97 Million |
0.053x | +134.27% |
| 2023-12-31 | CHF56.71 Million ≈ $71.70 Million |
CHF-8.84 Million ≈ $-11.18 Million |
-0.156x | -46.14% |
| 2022-12-31 | CHF68.86 Million ≈ $87.06 Million |
CHF-7.35 Million ≈ $-9.29 Million |
-0.107x | -50.63% |
| 2021-12-31 | CHF76.98 Million ≈ $97.32 Million |
CHF-5.45 Million ≈ $-6.89 Million |
-0.071x | +35.13% |
| 2020-12-31 | CHF84.60 Million ≈ $106.96 Million |
CHF-9.24 Million ≈ $-11.68 Million |
-0.109x | +21.63% |
| 2019-12-31 | CHF77.86 Million ≈ $98.43 Million |
CHF-10.85 Million ≈ $-13.72 Million |
-0.139x | +16.98% |
| 2018-12-31 | CHF76.48 Million ≈ $96.70 Million |
CHF-12.84 Million ≈ $-16.23 Million |
-0.168x | -14.97% |
| 2017-12-31 | CHF73.14 Million ≈ $92.47 Million |
CHF-10.68 Million ≈ $-13.50 Million |
-0.146x | +37.09% |
| 2016-12-31 | CHF38.32 Million ≈ $48.45 Million |
CHF-8.89 Million ≈ $-11.24 Million |
-0.232x | +93.82% |
| 2015-12-31 | CHF669.00K ≈ $845.80K |
CHF-2.51 Million ≈ $-3.18 Million |
-3.758x | -514.73% |
| 2014-12-31 | CHF-26.22 Million ≈ $-33.15 Million |
CHF-23.76 Million ≈ $-30.04 Million |
0.906x | +119.99% |
| 2013-12-31 | CHF4.23 Million ≈ $5.35 Million |
CHF-19.17 Million ≈ $-24.24 Million |
-4.532x | -293.95% |
| 2012-12-31 | CHF10.03 Million ≈ $12.68 Million |
CHF-11.54 Million ≈ $-14.59 Million |
-1.150x | -252.56% |
| 2011-12-31 | CHF-11.68 Million ≈ $-14.77 Million |
CHF-8.81 Million ≈ $-11.13 Million |
0.754x | +206.14% |
| 2010-12-31 | CHF6.59 Million ≈ $8.34 Million |
CHF-4.68 Million ≈ $-5.92 Million |
-0.710x | +61.61% |
| 2009-12-31 | CHF8.24 Million ≈ $10.42 Million |
CHF-15.25 Million ≈ $-19.28 Million |
-1.850x | -111.33% |
| 2008-12-31 | CHF31.86 Million ≈ $40.28 Million |
CHF-27.89 Million ≈ $-35.27 Million |
-0.876x | -983.67% |
| 2007-12-31 | CHF54.43 Million ≈ $68.82 Million |
CHF-4.40 Million ≈ $-5.56 Million |
-0.081x | +87.07% |
| 2006-12-31 | CHF45.90 Million ≈ $58.03 Million |
CHF-28.67 Million ≈ $-36.25 Million |
-0.625x | -70.75% |
| 2005-12-31 | CHF74.01 Million ≈ $93.57 Million |
CHF-27.08 Million ≈ $-34.23 Million |
-0.366x | -29.32% |
| 2004-12-31 | CHF80.17 Million ≈ $101.36 Million |
CHF-22.68 Million ≈ $-28.68 Million |
-0.283x | -- |
About Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; Ma… Read more